In order to achieve its investment objective

The Biotech Growth Trust invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.

Find out more about us

logo-orbimed-black.svg

Investor Update Webinar October 2024

View more videos

Factsheets

View factsheet archive

How to invest

The Company’s shares are traded openly on the London Stock Exchange and can be purchased through a stock broker or other financial intermediary.

Find out more

£329.5m

Our Net Asset Value*

14.6%

Five year share price (total return)*

13.2%

Five year Net Asset Value per share (total return)*

 

Source: Frostrow Capital LLP

*As at 30 November 2024